Global Uterine Cancer Radiation Therapies and Epidemiology - 2016

  • ID: 3692207
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Uterine Cancer Radiation Therapies and Epidemiology – 2016, provides insights into total Uterine Cancer patients on radiation therapies in top 7 markets, Uterine Cancer treatable patients, and Uterine Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Uterine Cancer specialists, oncologists, and Uterine Cancer patients to identify the Uterine Cancer patients in top 7 markets who were treated by radiation therapies. The research also identifies total Uterine Cancer patients’ on radiation therapies by Uterine Cancer stages.
Uterine cancer patients undergo radiation therapy (External beam radiation, Brachytherapy) as a part of their treatment. This study accurately determines and forecast Uterine Cancer patients who were on radiation therapies in a given year. This research also provides insights into Uterine Cancer epidemiology including Uterine Cancer incidence and Uterine Cancer prevalence by Uterine Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Uterine Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Uterine Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Uterine Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Uterine Cancer Patients on radiation therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Uterine Cancer market potential, Uterine Cancer radiation therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Uterine Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on Radiation Therapies
3. Uterine Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on Radiation Therapies
4. Uterine Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on Radiation Therapies
5. Uterine Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on Radiation Therapies
6. Uterine Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on Radiation Therapies
7. Uterine Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on Radiation Therapies
8. Uterine Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on Radiation Therapies
9. Uterine Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on Radiation Therapies
10. Glossary

1. Uterine Cancer Incidence by Stages, Global, 2010 - 2025
2. Uterine Cancer Prevalence by Stages, Global, 2010 - 2025
3. Uterine Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Uterine Cancer Patients on Radiation Therapies by Stages, Global, 2010 – 2025
5. Uterine Cancer Incidence by Stages, Germany, 2010 - 2025
6. Uterine Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Uterine Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Uterine Cancer Patients on Radiation Therapies by Stages, Germany, 2010 - 2025
9. Uterine Cancer Incidence by Stages, France, 2010 - 2025
10. Uterine Cancer Prevalence by Stages, France, 2010 - 2025
11. Uterine Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Uterine Cancer Patients on Radiation Therapies by Stages, France, 2010 - 2025
13. Uterine Cancer Incidence by Stages, Italy, 2010 - 2025
14. Uterine Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Uterine Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Uterine Cancer Patients on Radiation Therapies by Stages, Italy, 2010 - 2025
17. Uterine Cancer Incidence by Stages, Spain, 2010 - 2025
18. Uterine Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Uterine Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Uterine Cancer Patients on Radiation Therapies by Stages, Spain, 2010 - 2025
21. Uterine Cancer Incidence by Stages, UK, 2010 - 2025
22. Uterine Cancer Prevalence by Stages, UK, 2010 - 2025
23. Uterine Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Uterine Cancer Patients on Radiation Therapies by Stages, UK, 2010 – 2025
25. Uterine Cancer Incidence by Stages, Japan, 2010 - 2025
26. Uterine Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Uterine Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Uterine Cancer Patients on Radiation Therapies by Stages, Japan, 2010 – 2025
29. Uterine Cancer Incidence by Stages, US, 2010 - 2025
30. Uterine Cancer Prevalence by Stages, US, 2010 - 2025
31. Uterine Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Uterine Cancer Patients on Radiation Therapies by Stages, US, 2010 - 2025

1. Uterine Cancer Incidence, Global, 2010 – 2025
2. Uterine Cancer Incidence – Stage I, Global, 2010 – 2025
3. Uterine Cancer Incidence – Stage II, Global, 2010 - 2025
4. Uterine Cancer Incidence – Stage III, Global, 2010 - 2025
5. Uterine Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Uterine Cancer Prevalence, Global, 2010 - 2025
7. Uterine Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Uterine Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Uterine Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Uterine Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Uterine Cancer Treatable Patients, Global, 2010 - 2025
12. Uterine Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Uterine Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Uterine Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Uterine Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Uterine Cancer Patients on Radiation Therapies, Global, 2010 - 2025
17. Total Uterine Cancer Patients on Radiation Therapies – Stage I, Global, 2010 – 2025
18. Total Uterine Cancer Patients on Radiation Therapies – Stage II, Global, 2010 – 2025
19. Total Uterine Cancer Patients on Radiation Therapies – Stage III, Global, 2010 – 2025
20. Total Uterine Cancer Patients on Radiation Therapies – Stage IV, Global, 2010 – 2025
21. Uterine Cancer Incidence by Stages, Germany, 2010 – 2025
22. Uterine Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Uterine Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Uterine Cancer Patients on Radiation Therapies, Germany, 2010 - 2015
25. Uterine Cancer Incidence by Stages, France, 2010 – 2025
26. Uterine Cancer Prevalence by Stages, France, 2010 – 2025
27. Uterine Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Uterine Cancer Patients on Radiation Therapies, France, 2010 – 2025
29. Uterine Cancer Incidence by Stages, Italy, 2010 – 2025
30. Uterine Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Uterine Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Uterine Cancer Patients on Radiation Therapies, Italy, 2010 – 2025
33. Uterine Cancer Incidence by Stages, Spain, 2010 – 2025
34. Uterine Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Uterine Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Uterine Cancer Patients on Radiation Therapies, Spain, 2010 - 2015
37. Uterine Cancer Incidence by Stages, UK, 2010 – 2025
38. Uterine Cancer Prevalence by Stages, UK, 2010 – 2025
39. Uterine Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Uterine Cancer Patients on Radiation Therapies, UK, 2010 – 2025
41. Uterine Cancer Incidence by Stages, Japan, 2010 – 2025
42. Uterine Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Uterine Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Uterine Cancer Patients on Radiation Therapies, Japan, 2010 – 2025
45. Uterine Cancer Incidence by Stages, US, 2010 – 2025
46. Uterine Cancer Prevalence by Stages, US, 2010 – 2025
47. Uterine Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Uterine Cancer Patients on Radiation Therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll